Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genentech, Inc.
With
Hoffmann-La Roche
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patients 18-80 years of age
RA for ≥ 2 months;
Receiving outpatient treatment
Patients naive to, and considered to be candidates for, methotrexate treatment
You may not be if
Rheumatic autoimmune disease other than RA, or significant systemic involvement secondary to RA
Inflammatory joint disease other than RA, or other systemic autoimmune disorder
Diagnosis of juvenile rheumatoid arthritis, or RA before the age of 16
Surgery within 12 weeks of study
Previous treatment with any approved or investigational biologic agent for RA, an anti-alpha4-integrin antibody or co-stimulation modulator, or cell-depleting therapy
Concurrent treatment with any biologic agent or DMARD other than methotrexate
